Help Desk :
1800 8899 868
info@digidxdoc.com
Koramangala,
Bengaluru
Our expert panel second opinion pathologists include nationally recognized pathologists working in renowned medical schools or specialty trained pathologist from USA and Europe.
DigiPath offers expert opinions from histopathologists in Mumbai, across India, and globally. Our panel comprises highly qualified specialists with deep expertise in specific organs and systems. Instead of generalists, we have organ-specific experts, ensuring thorough and specialized analysis. View our expert panel and choose the right specialist for your case.
DigiPath offers expert opinions from histopathologists in Mumbai, across India, and globally. Our panel comprises highly qualified specialists with deep expertise in specific organ systems. Unlike general histopathologists, our experts focus on specific areas, ensuring in-depth analysis tailored to your needs. Explore our panel of histopathology experts and select the ideal specialist for your case.
Brain tumors rank as the 10th most prevalent among Indians, comprising both cancerous and non-cancerous types, originating either within the brain (primary) or spreading from other parts of the body (secondary). While the exact cause remains uncertain, potential risk factors include radiation exposure and familial predisposition.
Breast cancer reigns as the most prevalent cancer among women globally, and its incidence is notably escalating among urban Indian females. Strikingly, approximately one-third of breast cancer cases exhibit familial patterns, hinting at genetic predispositions. Within this subset, around 5% are deemed hereditary, with mutations in the BRCA1 and BRCA2 genes identified as significant contributors.
Lung cancer is a significant health concern in India, particularly among males, and its impact is expected to grow. While historically affecting older male smokers with squamous or small cell carcinoma, there's a notable shift towards younger individuals, non-smokers, and females, often with adenocarcinoma. Many patients present with advanced disease. Fortunately, advancements in molecular testing, radiation technology, and generic drug availability have improved treatment efficacy.
Gastrointestinal (GI) cancers are prevalent and often fatal, comprising various types such as gastric, colorectal, hepatocellular, esophageal, and pancreatic cancer. They collectively rank among the most common and deadly cancers globally, posing significant challenges to healthcare. Despite advancements, the 5-year survival rates for these cancers remain comparatively low, underscoring the urgent need for improved prevention, detection, and treatment strategies.
CKD is a major public health issue due to its prevalence and mortality. Nephrologists assess kidney failure risk based on experience. Globally, kidney biopsy rates rise, aiding diagnosis and treatment. Pathological evaluation of biopsy specimens is crucial. Advancements in techniques enhance diagnostic capabilities, with potential for further improvement.
Renal cell carcinoma (RCC), mainly affecting the elderly, constitutes 3% of adult cancers and 85% of kidney tumors. Symptoms include hematuria or abdominal lumps, often detected incidentally via CT scan or ultrasonography. Urothelial carcinoma of the bladder ranks fourth in men and eighth in women in the Western world, with symptoms like hematuria and urinary changes.
Male genitourinary cancers account for 17.48% of all malignancies. Prostate cancer ranks second in incidence and sixth in cancer-related mortality, primarily affecting elderly men, with three-quarters of cases occurring in those aged 65 or older. Testicular cancer is rare in the Indian subcontinent, with an incidence of less than 1 per 100,000.
Gynaecological cancers affect the female reproductive system, including uterine/endometrial, ovarian, cervical, vaginal, vulvar, fallopian tube, and trophoblastic tumors. In India, around 50-60% of women's malignancies originate from the cervix, breast, uterus, and ovaries. Screening often detects these cancers. Treatment varies based on cancer type, stage, location, and overall health.
Blood cancer, including leukemia, lymphoma, and myeloma, originates from DNA mutations affecting blood cells. It can affect both children and adults, with symptoms and treatment differing between age groups. In these cancers, abnormal blood cell growth disrupts normal function, compromising the body's ability to fight infections and control bleeding. Over one lakh people in India are diagnosed with blood cancer annually.
Sarcoma originates in the body's soft tissues and can affect various organs. It commonly occurs in the arms and legs. Primary bone cancer, rare compared to secondary bone cancer, begins in bone cells. Most bone cancers originate elsewhere in the body and spread to the bone, with the long bones of the arms and legs, pelvis, ribs, and spine commonly affected.
Skin cancer, often a result of sun exposure, includes squamous cell carcinoma, basal cell carcinoma, and melanoma. Avoiding UV radiation reduces the risk. Early detection is crucial for successful treatment.
Pediatric cancer is rare, affecting approximately 1 in 285 children before age 20. It can manifest in various parts of the body, including blood, lymph nodes, CNS, kidneys, and other organs. Often, the cause is unknown. Childhood cancers may differ significantly from adult cancers, even in the same location. Ongoing research aims to develop new treatments, significantly improving survival rates, now exceeding 80%.